Zhejiang Tiantai Xianghe Industrial Co Ltd

China Nerin signed a contract with KONKOLA COPPER MINES PLC for a new 70,000-tonne-per-year copper tailings leach plant project in Zambia, with a contract value of approximately $498 million, equivalent to about 3.378 billion yuan. The project uses a hydrometallurgical leaching process to recover valuable metals from existing copper tailings, with China Nerin responsible for design, procurement, construction and installation, commissioning, and technical support services. On the same day, the controlling shareholder of Fujian Expressway plans to increase its shareholding by no less than 130 million yuan and no more than 230 million yuan, with the increase not exceeding 2% of total share capital. Fulongma signed a sanitation autonomous driving technology development contract with Huawei Cloud Computing, with a total contract value of 200 million yuan and a term of three years, under which Huawei Cloud Computing will exclusively develop and deploy the Fulongma sanitation autonomous driving system for the company. Xianghe Industrial signed a railway fastener system component purchase and sale contract with Zhongyuan Lida Railway Track Technology Development Co., Ltd., with a total contract value of 178 million yuan, accounting for approximately 21.32% of the company's audited 2025 revenue.

Kuang-Chi Technologies' wholly owned subsidiary Kuang-Chi Advanced Technology will deliver supermaterials structural products worth a total of 907 million yuan to three customers. That evening, several listed companies disclosed major contracts and capital operations: Zhejiang Construction Investment Group's subsidiary won a public housing development project bid of about 1.5 billion Hong Kong dollars, Xianghe Industrial signed a 178 million yuan railway fastener system components sales contract, Fulongma signed a 200 million yuan sanitation autonomous driving technology development contract with Huawei Cloud Computing, and Aidea Pharmaceutical plans a private placement to raise no more than 945 million yuan for the global clinical development of a novel HIV integrase inhibitor and other projects. Hengrui Pharmaceuticals repurchased 335,000 A-shares for the first time that day, paying 14.5036 million yuan. Longshen Rongfa's controlling subsidiary's marketing application for brexpiprazole oral dissolving film was not approved. In that day's Dragon-Tiger List, MetaX, one of the leading domestic GPU companies, saw the largest net institutional selling of 2.142 billion yuan, while its share price rose more than 14 percent; Ruifeng Advanced Materials saw the largest net institutional buying of 212 million yuan.